FindTrial
Sign In

Comparison of Dexmedetomidine by two different routes with bupivacaine in ultrasound guided block for upper limb surgeries.

A comparative study of dexmedetomidine by two different routes as an adjunct to bupivacaine in usg guided supraclavicular block for upper limb surgeries- A prospective randomized placebo controlled triple blind study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/08/015389
Enrollment
90
Registered
2018-08-20
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Patients undergoing Elective Surgeries in Supraclavicular Block

Interventions

Intervention1: Brachial Block: Ultasound Guided Supraclavicular Block Control Intervention1: Bupivacaine: 20 ml of 0.5% Bupivacaine + 1ml Normal Saline and 1ml Normal Saline intramuscular Control Int

Sponsors

Dr RPGMC Kangra at Tanda
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. ASA class I-II 2. BMI 18.5-29.9 3. Undergoing surgeries around midarm, elbow, forearm and hand

Exclusion criteria

Exclusion criteria: 1. Patientâ??s refusal for block 2. History of cardiac, renal or hepatic disease, CNS disorders,neuropathy 3. Patients having bleeding disorders 4. Hypersensitivity to local anesthetics 5. Local infection at the site where needle for block is to be inserted 6. Patients noted to have dysrhythmias on the electrocardiogram (ECG) 7. Allergic to study drugs 8. Patients in whom the block effect will be partial and will require supplementary anesthesia

Design outcomes

Primary

MeasureTime frame
To study and compare the onset and duration of sensory and motor blockade with two different routes of dexmedetomidine viz. perineural and intramuscular as an adjuvant to 0.5% bupivacaine in ultrasound guided supraclavicular brachial plexus block in patients scheduled for upper limb orthopaedic surgeriesTimepoint: 24 hours—

Secondary

MeasureTime frame
â?¢ To study and compare the hemodynamic stability of two different routes of dexmedetomidine.Timepoint: 24 HOURS;To observe for side effects of dexmedetomidine in two different routes, if any.Timepoint: 24 HOURS;To study and compare sedation with different routes of dexmedetomidineTimepoint: 24 HOURS—

Countries

India

Contacts

Public ContactDr Shyam Bhandari

Rajendra Prasad Govt. Medical College, Kangra at Tanda (H.P.)

dr.bhandari@yahoo.co.in9805098588

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026